We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-3.47%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$119B
AUM Growth
-$5.47B
Cap. Flow
+$963M
Cap. Flow %
0.81%
Top 10 Hldgs %
23.93%
Holding
4,385
New
262
Increased
2,061
Reduced
1,644
Closed
273

Sector Composition

Rank Sector Weight
1 Technology 14.55%
2 Financials 8.84%
3 Healthcare 8.46%
4 Industrials 6.23%
5 Consumer Discretionary 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAON icon
2151
Aaon
AAON
$7.24B
$1.96M ﹤0.01%
52,695
-338
-0.6% -$13.8K
FSBW icon
2152
FS Bancorp
FSBW
$323M
$1.96M ﹤0.01%
63,109
-4,455
-7% -$145K
KB icon
2153
KB Financial Group
KB
$42B
$1.95M ﹤0.01%
39,975
-2,033
-5% -$100K
VHI icon
2154
Valhi
VHI
$460M
$1.95M ﹤0.01%
66,345
-2,375
-3% -$64.6K
MDU icon
2155
MDU Resources
MDU
$4.35B
$1.94M ﹤0.01%
191,390
-282,410
-60% -$2.99M
WWD icon
2156
Woodward
WWD
$21.8B
$1.94M ﹤0.01%
15,492
-209
-1% -$24.6K
ITRN icon
2157
Ituran Location and Control
ITRN
$1.06B
$1.93M ﹤0.01%
83,945
-1,186
-1% -$27.6K
RSPH icon
2158
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$794M
$1.92M ﹤0.01%
62,760
-31,780
-34% -$951K
H icon
2159
Hyatt Hotels
H
$17B
$1.92M ﹤0.01%
20,080
-1,554
-7% -$146K
SVAL icon
2160
iShares US Small Cap Value Factor ETF
SVAL
$212M
$1.92M ﹤0.01%
62,427
+6,050
+11% +$189K
AMED
2161
DELISTED
Amedisys
AMED
$1.91M ﹤0.01%
11,101
+680
+7% +$102K
SPPP
2162
Sprott Physical Platinum and Palladium Trust
SPPP
$613M
$1.91M ﹤0.01%
118,406
+8,223
+7% +$134K
HR icon
2163
Healthcare Realty
HR
$6.61B
$1.9M ﹤0.01%
60,764
+5,307
+10% +$167K
PEN icon
2164
Penumbra
PEN
$12.9B
$1.9M ﹤0.01%
8,565
+641
+8% +$142K
REYN icon
2165
Reynolds Consumer Products
REYN
$5.53B
$1.9M ﹤0.01%
64,637
+4,280
+7% +$128K
TNDM icon
2166
Tandem Diabetes Care
TNDM
$1.57B
$1.9M ﹤0.01%
16,299
-5,393
-25% -$630K
PBJ icon
2167
Invesco Food & Beverage ETF
PBJ
$108M
$1.89M ﹤0.01%
41,004
+10,808
+36% +$485K
TAK icon
2168
Takeda Pharmaceutical
TAK
$56.2B
$1.89M ﹤0.01%
132,226
+29,087
+28% +$427K
GPI icon
2169
Group 1 Automotive
GPI
$3.13B
$1.89M ﹤0.01%
11,265
-2,091
-16% -$380K
ONEQ icon
2170
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.9B
$1.89M ﹤0.01%
33,976
+9,035
+36% +$493K
BILL icon
2171
BILL Holdings
BILL
$4.96B
$1.88M ﹤0.01%
8,301
+306
+4% +$63.8K
EWT icon
2172
iShares MSCI Taiwan ETF
EWT
$11.5B
$1.88M ﹤0.01%
30,602
-19,690
-39% -$1.26M
CGW icon
2173
Invesco S&P Global Water Index ETF
CGW
$1.06B
$1.88M ﹤0.01%
35,862
-37,517
-51% -$1.99M
MTH icon
2174
Meritage Homes
MTH
$4.76B
$1.88M ﹤0.01%
47,458
-18,526
-28% -$905K
LW icon
2175
Lamb Weston
LW
$7.33B
$1.88M ﹤0.01%
31,305
+11,741
+60% +$729K

Similar funds

Raymond James & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Raymond James & Associates held 4,385 positions worth $119B, down 4.4% from $124B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q1 2022 filing shows 262 new, 2,061 increased, 1,644 reduced and 273 closed positions. Its largest new stake was Shell: 688,334 shares worth $37.8M. The largest sale was iShares Ultra Short Duration Bond Active ETF, an estimated $172M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q1 2022 buy was Shell: 688,334 shares worth $37.8M.
  • Raymond James & Associates added most to Broadcom in Q1 2022, an estimated $236M increase.
  • Raymond James & Associates's biggest Q1 2022 reduction was iShares Ultra Short Duration Bond Active ETF, cutting an estimated $172M.
  • Raymond James & Associates fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $154M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $119B portfolio in Q1 2022.
  • Raymond James & Associates opened 262 new positions and closed 273 in Q1 2022.
  • Raymond James & Associates's portfolio value fell 4.4% quarter-over-quarter to $119B.

Based on Raymond James & Associates's 13F filing for Q1 2022, filed 11 May 2022.